Učitavanje...
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
The pharmacoenhancement of plasma concentrations of protease inhibitors by coadministration of so-called boosters has been an integral part of antiretroviral therapy for human immunodeficiency virus (HIV) for 1.5 decades. Nearly all HIV protease inhibitors are combined with low-dose ritonavir or cob...
Spremljeno u:
| Izdano u: | HIV AIDS (Auckl) |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4694690/ https://ncbi.nlm.nih.gov/pubmed/26730211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S70836 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|